FDAnews
www.fdanews.com/articles/159711-mimetogen-starts-patient-enrollment-in-phase-iii-study-of-eye-drug

Mimetogen Starts Patient Enrollment in Phase III Study of Eye Drug

October 15, 2013
Mimetogen Pharmaceuticals has enrolled its first patients in a Phase III study of MIM-D3 ophthalmic solution for dry eyes.
Pharmaceutical Business Review